Virna Schuck
International Drug Development(FR)Ribon Therapeutics (United States)(US)Foghorn Therapeutics (United States)(US)
Publications by Year
Research Areas
Chromatin Remodeling and Cancer, Antibiotics Pharmacokinetics and Efficacy, Antibiotic Resistance in Bacteria, Cancer therapeutics and mechanisms, Pneumonia and Respiratory Infections
Most-Cited Works
- → Translating slow-binding inhibition kinetics into cellular and in vivo effects(2015)149 cited
- → Comparative In Vitro and In Vivo Efficacies of Human Simulated Doses of Ceftazidime and Ceftazidime-Avibactam against Pseudomonas aeruginosa(2012)115 cited
- → Pharmacodynamics of Ceftazidime and Avibactam in Neutropenic Mice with Thigh or Lung Infection(2015)101 cited
- → Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases(2015)100 cited
- → Model‐Informed Drug Development for Anti‐Infectives: State of the Art and Future(2021)73 cited
- → Model-based drug discovery: implementation and impact(2013)67 cited